Seung Soo Han

Title: Innovations of Seung Soo Han in Biopharmaceuticals

Introduction

Seung Soo Han is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on interferon-alpha fusion proteins. His research focuses on enhancing the efficacy and delivery of therapeutic proteins.

Latest Patents

Seung Soo Han holds a patent for an interferon-alpha fusion protein in which a cytoplasmic transduction peptide and polyethylene glycol are bonded to one another. This invention is characterized by maintaining high specific activity of interferon, extending the half-life of the fusion protein when delivered in vivo, and improving the mobility of interferon in the liver. The implications of this patent are profound, as it can be utilized in developing protein drugs effective in preventing or treating liver diseases, including various types of viral infections.

Career Highlights

Seung Soo Han is associated with Jw Creagene Inc., where he continues to advance his research in the biopharmaceutical sector. His work is pivotal in the development of innovative therapies that can significantly impact patient care.

Collaborations

He collaborates with esteemed colleagues such as Yong Soo Bae and Seung Ho Hong, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Seung Soo Han's contributions to the field of biopharmaceuticals through his patent on interferon-alpha fusion proteins highlight his role as a leading inventor. His work not only enhances therapeutic options but also paves the way for future advancements in treating liver diseases.